Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is about 1/2 of the OS. The 10-Q filed last week showed about 41 million in the OS. But if you look at the shares traded the last 12 months, it is tiny!!!! Something 3 million shares traded for the entire year IIRC.
No, I don't see it. I see MNLU and AEXP inexorably attached at the hip now. Someone is spreading rumors behind the scenes that are pure non sense. In fact I think we have bottomed as the shorts or those that wanted to buy at lower prices later this year seemed to have missed the boat, and now they are trying to throw mud anywhere they can to shake loose cheap shares. We might retest the recent lows in the next weeks, but the MM's may not let us have the few cheap shares they shake loose next trip down. If we get asks at or below .30 again, I would grab all you can, as we should be well over $1 by late July! Mark my WORDS!!!!! Today was an early sign of the bottom!
The AEXP tanking is over. Somebody panicked and sold or try to take the price down. I tried to grab those .06 shares (AEXP) when they showed up (38,000 apx), but they were gone before my bid reached the order desk. Now the bid is where the ask was, with lots of volume. Somebody did this last week, trying to push it down .05, but it was back at .09 this morning. Could be MM games, or somebody just hit the wrong button, "Fat fingers", and hit sell instead of ask! It does happen! Don't ask me how I know!!!! LOL
Something big is happening! Huge up volume today.
Probably attract short selling sharks to the entire sector.
Legal contracts between MNLU, AEXP, and Guggenheim suggest otherwise!
Seems that MNLU will be connected to the pipe line late in the third quarter this year, and begin producing some substantial cash flow (minimal NG flow) the last quarter of this year, if all goes as planned. Increased NG flow would require pipeline capacity expansion.
Also I found out today that the well site itself, and the pipeline itself do not flood, not even with this years record flood levels. It is the access road that floods. Even if it did flood, production and flow would continue.
They should be able to cross that road in mid July, just like last year, right on schedule.
No, not this one. Investors are just unhappy that it has not shown a profit yet, in any of the recent reports as they caught up on their late reports. I will be buying again (loading the boat) at .30 to .50 very soon. By Feb 2012 this one is likely to hit $2/share when the big profits finally show up. The it will depend on how high the profits are, and how stable they are.
All about completed expansion of plant capacity, and a 10X increase in new orders that are now on the books for delivery this fall and winter. But it is likely to re-test .30 this summer, the next 3 months due to low volume!!!!
The "END" is not likely. They have way too much going for them. On the other hand, where the next bottom is, IS a good question. I added more shares yesterday. Will add big time if we go way down further. At some point it will bottom, and then from there it is likely to rally 500% (or even 1000%) into April 2011 IMHO. Just depends on how badly the price gets hammered. I think .50 is possible.
Why? What is it?
Historical perspective, of where MVTG has been, and about market potential, market and R&D efforts and direction for using Formic acid to fuel fuel cells.
Mantra (MVTG) has additional R&D and IP products, not just the ERC process. Also that info helps newbees get up to speed on the history here.
While MVTG has its own proprietary formic acid fuel cell IP, it is not yet in the engineering for a commercial unit stage, but the link / news I posted a few days ago shows others continuing to improve on the various hardware (catalysts) for formic acid cells, which helps improve the market outlook for formic acid over time.
MVTG is not a one trick horse. But right now ERC is its most important, immediate future horse. That horse produces formic acid, so uses of formic acid, including new ones, is relevant.
Hmm, You were saying?
LOL
I am still here, but I never bought shares (I was low on cash at the time, and it looked too risky). I was in and out of this sector a lot in late 08 and all of 09.
I am still keeping a close eye on it.
Check out the 10-Q today! Earnings for last quarter per share, were three times the stock price close today!!!!
WOW!!!!
NEWS!!!! BIG NEWS!!!! HUGE NEWS!!!!!Next stop should be $2/share!! Finally!!!
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS. If all of the development and commercialization milestones in the transaction agreement are met, in addition to an up-front payment, CytRx could receive total payments of up to $120 million, in addition to royalties on sales of products developed by Orphazyme from its molecular chaperone technology. This transaction represents the completion of CytRx’s previously announced, non-dilutive monetization strategy for its non-core assets.
“This could be a game-changing transaction for CytRx with an ultimate potential value that exceeds our current market capitalization,” said President and Chief Executive Officer Steven A. Kriegsman. “It illustrates our exceptional execution of a strategy to acquire assets and add value, in this case through multiple clinical and preclinical trials, then monetize them to support our focus on oncology.”
Orphazyme was formed in 2009 to develop molecular chaperone therapies to treat rare genetic lysosomal diseases. Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases. The company’s strategy is based on pioneering discoveries on the cytoprotective properties of human heat shock proteins, with the aim of developing paradigm-changing treatments for lysosomal storage diseases.
Orphazyme is backed by Novo A/S and Sunstone Capital. Novo A/S, which is wholly owned by the Novo Nordisk Foundation, is an international financial venture fund with offices in Copenhagen, San Francisco and London. Sunstone Capital is a Nordic-based early stage venture capital investor founded by an international team with more than 200 years of combined entrepreneurial, operational and financial experience.
The CytRx molecular chaperone portfolio includes three drug candidates, arimoclomol, iroxanadine and bimoclomol, which are orally administered molecular chaperone amplifiers. The compounds collectively have proven to be safe and well tolerated in more than 680 human subjects tested in 13 Phase 1 and six Phase 2 clinical trials. By targeting the underlying cause of many diseases, this novel approach has the potential to be developed for a broad variety of indications, including genetic diseases.
Mr. Kriegsman added, “We are delighted to place these important molecular chaperone assets in the hands of the world-class scientists at Orphazyme for further development with the ultimate goal of commercialization. We are pleased that the management team and Board of Directors of Orphazyme share our vision that molecular chaperones have the potential to improve the lives of patients worldwide. This transaction provides us with additional resources to focus on our highly promising oncology drug candidates.”
Orphazyme Chief Executive Officer Anders Hinsby, Ph.D., stated, “We are developing paradigm-changing medicines for the treatment of individuals with inherited genetic lysosomal storage diseases for which there are currently no cures. All of these diseases share a common characteristic in that they originate from a deficiency in the ability of the lysosomes to metabolize macromolecules. We believe that CytRx’s molecular chaperone technology can be used to revert lysosomal pathology through the induction of heat shock proteins, such as HSP70, and thus can be applied to develop new treatments for these diseases.”
CytRx is focused on advancing its oncology portfolio and currently has six clinical trials underway and one additional clinical trial planned with its oncology drug candidates, bafetinib, tamibarotene and INNO-206. Preliminary data from the Company’s clinical trial of bafetinib in advanced-stage leukemia is expected this quarter. In pursuing its strategy to monetize non-oncology assets, CytRx recently completed its sale of common stock in RXi Pharmaceuticals (Nasdaq: RXII), successfully raising a total of approximately $17 million from its former RNAi assets. Additionally, CytRx received 163,000 shares of common stock of ADVENTRX Pharmaceuticals (of which approximately 20% are being held in escrow) in exchange for its 19.1% stake in SynthRx. If all milestones under that agreement are achieved, CytRx could receive up to 2.9 million additional shares of ADVENTRX. The last sale price of ADVENTRX (NYSE Amex: ANX) shares on the NYSE Amex on May 13, 2011 was $2.58.
Negative?
LOL, surely you gest? LOL
Two main plants. They kept the one they bought in Ca, Ganzalos. And expanded production there earlier this year with new (toxic) debt, to meet sales. They had no cash, no working capital, after the settlement over the Woodbridge, NJ plant assets and debt, when they abandoned it, and they refinanced with two 5 million dollar loans, that allow 90% share dilution based on the stock price, debt conversion to stock. It is all in the last 2 SEC reports, 10-Q, and 8-K. What they (and we) need is a huge Terra sale, cash up front, deal!!!!! IN the millions of dollars.
They barely avoided bankruptcy, with an "oh look there is a Kitty" merger distraction, and walked away from the original fertilizer (organic) plant they built and the debt on it, with share dilution......, and now they are funding losses with ultra toxic debt/share swap deals. Survival still hinges on sales growth.
Great Caesars Ghost!!!!
MHAN just reported a .03/share profit last quarter!!!!!
Shares at .011 bid, .015 ask!!!!!
Let buying spree begin!!!
http://files.shareholder.com/downloads/MHA/1259621366x0xS1144204-11-29653/1001316/1144204-11-29653.pdf
HEADS UP PEOPLE!!!
Insider, Director of MVTG bought 62,500 shares at .08/share
Check the Form 4 just filed today!!!!
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001432453-11-000051.txt&FilePath=\2011\05\16\&CoName=MANTRA+VENTURE+GROUP+LTD.&FormType=4&RcvdDate=5%2F16%2F2011&pdf=
Byron actually has an excellent past pedigree. He was a VP of AOL, involved in media at AOL (advertising, and AOL did quite well after early start up costs.....) in the early days of promoting AOL. I researched him 3 years ago, before I bought early shares). He put his experience to good use, making CABN and it's CO2 to fuel dream, a household name in the chemical, oil and gas industry, and in the penny stock world.
My concern is, will this Zebra changes its stripes (never ending dilution at 66% discount), and if so, when. Until then, I can't see drinking the latest koolaid here.
So far all we have is 3 years of promises, and missed targets. No issued patents, no 3rd party patent examination opinions issued. Just an R&D plan, on the 3rd or fourth idea, with the prior 3 plans parked on the shelf. And we on to our 3rd or fourth inventor on the IP team, with at least 2 prior inventors, packed up and gone.
News on formic acid fuel cell catalyst R&D:
http://www.rsc.org/chemistryworld/News/2011/April/11041101.asp
Only three out of 30 of my stocks are green today, and ABAT is winning the race to the green side, UP!
Going UP?
TTEG just turned on a dime moments ago!!!
Up from .16 to .20, rather suddenly, with bids and ask raised!!!!
Not sure why? News???
Last 2 day sell off, is not inspiring much confidence in COIN. Could MM's be covering shares sold short on Thursday's huge rally, and they walked it down to cover before the conference tomorrow IN fear of a bigger rally tomorrow?
Or is this real profit taking, and lack of confidence in the conference news tomorrow?
Stayed tuned to your L-2 levels for the answer tomorrow morning!
One thing is for sure, if the news tomorrow is a dud, no real news, we head to .10 fast IMHO. If their is real news, Thursday last week was just a test flight, with a .25 to .30 target on major news tomorrow!
Edit: Dropping more now!!! Everyone heading for the exits before the news!
This horse has already lost 3 races, and keeps entering new races in the hopes it will win the lottery.
When Byron takes half his salary, and buys retail shares (not new shares at a 65% discount to retail) at retail with half his annual salary, that will get my attention!!!!
Selling new shares at 65% off of retail is not the way to treat retail investors. As it currently exists, there is no way this company and stock will make it to a big board to trade, unless some thing real actually happens besides endlessly entering new horse races with a new horse every 6-12 months.
IIRC the new available shares bylaws was raised to 500,000,000 shares from 200,000,000 while they did a 40:1 R/S.
Why would they raise it to 500,000,000 shares at the same time as R/S if they are not planning massive dilution, again, after a 40:1 R/S?
I still hope they come up with a viable new process, but after 3 years, I have lost my big risk appetite here, for now.
If you really want to play this stock go buy the cheap shares direct from CABN and sell them at retail to the dreamers for a 200% profit, to retail investors who can stomach 80% losses while they hold the bag, if you want make money here.
"
I disagree. Does matter if it is 1 foot of flood water, or 10 ft of flood water. Once it drains the bulk water off, it will dry the at the same rate either way, 10 ft, 20 ft, or 1 ft of water won't make a difference. Early peak record flood, could mean the rain came early and fast, instead of slow and late. I will got with MNLU's prior announced expected restart up dates. Hotter, dryer air in June will make a difference!!!
We are already having record highs in Houston, dry heat wave here.
The problem now days is management in these companies is paid on the basis of how much money they can loose, and how fast they can loose it!
Neither does a R/S, 40:1, and then selling new shares at 66% discount to retail!
These guys have been selling shares to insiders at 66% off, and then letting them sell at a 300% premium into the retail market to pay the bills!
I am now very leery of this outfit and its shares!
Someone correct me if I am wrong, that S-3 is all old news, simply doing an initial step of registering currently unsellable (at retail) shares we already knew about, from the synthrex merger deal earlier this year. Non of those shares are new, and 85% of them will not be issued for a long time, unless the Synthrex product wins FDA approval, and passes future trial tests.
Did I miss something, or did you guys miss the earlier take over news on Synthrex merger with ANX and buyout of remain CYTR shares?
I read that too, bottom of page 8, the form 10-Q filed on Friday. They claim the R/S was retroactive to:
See pg 230, 243, and pg 249-51, Table 24, 25 & 26.
http://www.prizecapital.net/Prize_Capital/Carbon_files/PB%20-%20ACCELERATING%20THE%20UPTAKE%20OF%20CCS%20-%20INDUSTRIAL%20USE%20OF%20CAPTURED%20CARBON%20DIOXIDE_3.pdf
LOL, We already "DISCOVERED" it!!!
As surging oil prices begin to dampen the strength of the global economic recovery, investors are hopeful that the fuel cell sector will get a boost from a stronger push for alternative sources of energy. Fuel cells can be used for vehicles, heating and cooling systems and backup power for cell phone towers. The Bedford Report examines the outlook for companies in the Industrial Electrical Equipment Industry and provides research reports on FuelCell Energy, Inc. (NASDAQ: FCEL) and Plug Power, Inc. (NASDAQ: PLUG). Access to the full company reports can be found at:
www.bedfordreport.com/2011-05-FCEL
www.bedfordreport.com/2011-05-PLUG
Fuel cells convert the stored energy in fuels like natural gas or hydrogen gas into electricity without combustion. They are somewhat similar to batteries, although fuel must be fed continuously to them. Fuel cells can operate on a variety of fuels, including natural gas and renewable fuels such as landfill gas.
Ford and Toyota have both stressed the importance of breaking the dependence on foreign oil and project that they could be mass producing the fuel cell cars by 2015. Executives at Toyota say the company aims to slash the cost of hydrogen fuel cell technology before it starts selling its fuel cell sedan. Shinzo Kobuki, senior managing director in charge of Toyota's battery technology says the goal is to bring the cost of the fuel stack and high-pressure hydrogen tank to one-twentieth of 2008 levels.
The Bedford Report releases regular market updates on the Industrial Electrical Equipment Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.
FuelCell Energy recently said its fiscal first-quarter loss narrowed on strong product sales, resulting in better-than-expected revenue growth. The company makes fuel cells for electric power generation for commercial, industrial, municipal and utility customers and reported a loss of $11.7 million, or 10 cents a share, compared with a year-earlier loss of $15.4 million, or 18 cents a share.
Plug Power, meanwhile, saw its most successful quarter in the company's history during the first quarter of 2011, primarily based on the number of commercial orders it received. Total revenue for the first quarter was $6.0 million. This compares to total revenue of $4.4 million in the first quarter of 2010.
The Bedford Report provides Analyst Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.bedfordreport.com/disclaimer
Contact:
The Bedford Report
Well I am realizing that if one can do some tracking of stock warrants (serious DD) on a spread sheet, expiration datas, exercised warrants, one can predict large (even huge) surprise gains and losses on small cap stocks with a lot of warrants outstanding, where the profit or loss has nothing to do with the fundamental company operations, but has to do with what I consider BS derivative accounting, that probably confuses most investors, more so than it protects them. So for instance, if ABAT goes back to $6/share, with no change in warrants, I would sell at $6 before a nasty derivative loss hits the news on the next QRT report. In fact I am finally seeing, one of the big movers of many stocks that have puzzled me, that I have been missing early moves on, and reacting too late like a lamb to buy or sell!
I wish I had doubled up at the low last Friday, but I was waiting for a little lower price to add, and I was short on cash. (LOL, the only I ever short is cash, LOL). We could head back to $2 now I think. I still think too much like a long term buy and hold investor.
Volume is way back up also, already 1.2 million shares, and up nearly 13%.
CC, look again, you have it backwards. Reread my post and yours. Half of this quarters profit is due to drop in warrant value, due to drop in stock price. If stock price goes back to $4 before warrants expire, we take a loss of the derivative gain (and thus a net change of zero), but if the warrants expire first, we keep the gain.
Has COIN finally bottomed? We are up 13% already today, and we have news today, although I would not call it huge rally news?
Most of my penny stock are back up the last 2 days, in spite of the market sell off last 2 days. Maybe some kind of sector rotation underway, back into penny's this week?